Ocular Therapeutix, Inc.

US$6.59As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:OCULHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 1.54%
Div yield —
ROE (72.99%)
Biotechnology
Beta (5Y) 1.22
PE TTM —
TSR TTM (43.44%)
Mkt cap US$1.448B
ROIC (39.95%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$6.94
5.22%
(62.65%)
Hold 5|4|11|6|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.07
0.07
0.07
0.08
14.57%
18.67%
11.67%
25.66%
Revenue$M
63.11
62.75
61.93
61.21
(1.74%)
(0.02%)
(0.89%)
(2.65%)
Peers (US$1.448B)
Cap (US$)
PE
1.451B
—
Capital
TTM
5Y
10Y
Leveragex
2.604
(0.966)
(0.858)
EBIT/Intx
0.800
0.346
0.313
Own earn%
193.49
(201.47)
(170.17)
Sh yield%
40.75
39.06
39.29
Owners
Insiders/Inst%
11.73
35.93
Short interest%
4.60
SBC / revenue%
4.28
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
20–29
$1 testx
0.0
Incr. ROIC%
8